Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review-Reference-Cited by-同舟云学术

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review

Published:2016-08-04 Issue:8 Volume:11 Page:e0157385
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Muturi-Kioi Vincent,Lewis David,Launay Odile,Leroux-Roels Geert,Anemona Alessandra,Loulergue Pierre,Bodinham Caroline L.,Aerssens Annelies,Groth Nicola,Saul Allan,Podda Audino

Funder

Directorate-General for Research and Innovation

Innovative Medicines Initiative

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children;R Reading;Child: Care, Health and Development,2008

2. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents;ST O'Leary;Pediatrics,2012

3. Benign ethnic neutropenia: what is a normal absolute neutrophil count?;TB Haddy;The Journal of laboratory and clinical medicine,1999

4. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks;WW Reed;Archives of internal medicine,1991

5. Ethnic and sex differences in the total and differential white cell count and platelet count;BJ Bain;Journal of clinical pathology,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Congenital neutropenia: From lab bench to clinic bedside and back;Mutation Research/Reviews in Mutation Research;2024-01

2. Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study;Infectious Agents and Cancer;2023-10-17

3. Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV;AIDS;2023-08-23

4. Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity;Future Virology;2023-04

5. COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2;eClinicalMedicine;2023-02